Eli Lilly and Company
7 (METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES
Last updated:
Abstract:
The present invention provides a compound of Formula (I) wherein R is (II) or (III); or a pharmaceutically acceptable salt thereof, useful for treating psoriasis or systemic lupus erythematosus. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
4 Dec 2019
Issue date:
27 Jan 2022